Cartesian Therapeutics, Inc. (RNAC) Total assets 2016–2025
Cartesian Therapeutics, Inc. (RNAC) total assets at each fiscal year-end, per SEC filings.
$296.4MFY2025 · since FY2016: $89.3M → $296.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $296.4M | -31.9% |
| FY2024 | $435.0M | +42.6% |
| FY2023 | $305.1M | +83.9% |
| FY2022 | $165.9M | +3.8% |
| FY2021 | $159.9M | -3.4% |
| FY2020 | $165.4M | +66.2% |
| FY2019 | $99.6M | +123.8% |
| FY2018 | $44.5M | -56.0% |
| FY2017 | $101.1M | +13.2% |
| FY2016 | $89.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice